Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,132 shares at $475.34 ($2.5M) on 2025-02-27, disclosed to the SEC on 2025-02-28.
Scheduled sale ($2.5M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $479.61 | 2,482 | $1.2M | 48.6% |
| 2 | $475.34 | 2,650 | $1.3M | 51.4% |
| Total | $477.41 avg | 5,132 | $2.5M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-26 | $1.7M | — | Filing → |